Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease
- PMID: 18723162
- PMCID: PMC2613777
- DOI: 10.1016/j.biopsych.2008.06.020
Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease
Abstract
Background: The utility of combining early markers to predict conversion from mild cognitive impairment (MCI) to Alzheimer's Disease (AD) remains uncertain.
Methods: Included in the study were 148 outpatients with MCI, broadly defined, followed at 6-month intervals. Hypothesized baseline predictors for follow-up conversion to AD (entire sample: 39/148 converters) were cognitive test performance, informant report of functional impairment, apolipoprotein E genotype, olfactory identification deficit, and magnetic resonance imaging (MRI) hippocampal and entorhinal cortex volumes.
Results: In the 3-year follow-up patient sample (33/126 converters), five of eight hypothesized predictors were selected by backward and stepwise logistic regression: Pfeffer Functional Activities Questionnaire (FAQ; informant report of functioning), University of Pennsylvania Smell Identification Test (UPSIT; olfactory identification), Selective Reminding Test (SRT) immediate recall (verbal memory), MRI hippocampal volume, and MRI entorhinal cortex volume. For 10% false positives (90% specificity), this five-predictor combination showed 85.2% sensitivity, combining age and Mini-Mental State Examination (MMSE) showed 39.4% sensitivity; combining age, MMSE, and the three clinical predictors (SRT immediate recall, FAQ, and UPSIT) showed 81.3% sensitivity. Area under ROC curve was greater for the five-predictor combination (.948) than age plus MMSE (.821; p = .0009) and remained high in subsamples with MMSE > or = 27/30 and amnestic MCI.
Conclusions: The five-predictor combination strongly predicted conversion to AD and was markedly superior to combining age and MMSE. Combining the clinically administered measures also led to strong predictive accuracy. If independently replicated, the findings have potential utility for early detection of AD.
Figures
Similar articles
-
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.Neurology. 2007 Mar 13;68(11):828-36. doi: 10.1212/01.wnl.0000256697.20968.d7. Neurology. 2007. PMID: 17353470
-
Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.Neurology. 2008 Jan 15;70(3):191-9. doi: 10.1212/01.wnl.0000287091.57376.65. Neurology. 2008. PMID: 18195264 Clinical Trial.
-
(99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.Am J Geriatr Psychiatry. 2010 Nov;18(11):959-72. doi: 10.1097/JGP.0b013e3181ec8696. Am J Geriatr Psychiatry. 2010. PMID: 20808143 Free PMC article. Clinical Trial.
-
Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov. Report No.: 14-05198-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov. Report No.: 14-05198-EF-1. PMID: 24354019 Free Books & Documents. Review.
-
Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment.Curr Alzheimer Res. 2006 Apr;3(2):161-70. doi: 10.2174/156720506776383103. Curr Alzheimer Res. 2006. PMID: 16611017 Review.
Cited by
-
Tau propagation in the brain olfactory circuits is associated with smell perception changes in aging.Nat Commun. 2024 Jun 6;15(1):4809. doi: 10.1038/s41467-024-48462-3. Nat Commun. 2024. PMID: 38844444 Free PMC article.
-
Comparison of Cognitive Impairment Diagnosis Criteria in Clinical Settings: Conventional vs. Neuropsychological.Alpha Psychiatry. 2024 Mar 1;25(2):212-219. doi: 10.5152/alphapsychiatry.2024.231448. eCollection 2024 Mar. Alpha Psychiatry. 2024. PMID: 38798819 Free PMC article.
-
Influence of age on nicotinic cholinergic regulation of blood flow in rat's olfactory bulb and neocortex.J Physiol Sci. 2024 Mar 15;74(1):18. doi: 10.1186/s12576-024-00913-8. J Physiol Sci. 2024. PMID: 38491428 Free PMC article. Review.
-
Estimating dementia risk in an African American population using the DCTclock.Front Aging Neurosci. 2024 Jan 11;15:1328333. doi: 10.3389/fnagi.2023.1328333. eCollection 2023. Front Aging Neurosci. 2024. PMID: 38274984 Free PMC article.
-
Potential neural substrates underlying circadian and olfactory disruptions in preclinical Alzheimer's disease.Front Neurosci. 2023 Nov 29;17:1295998. doi: 10.3389/fnins.2023.1295998. eCollection 2023. Front Neurosci. 2023. PMID: 38094003 Free PMC article. Review.
References
-
- Di Carlo A, Lamassa M, Baldereschi M, et al. CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology. 2007;68:1909–1916. - PubMed
-
- Larrieu S, Letenneur L, Orgogozo JM, et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology. 2002;59:1594–1599. - PubMed
-
- Petersen RC. Mild cognitive impairment: current research and clinical implications. Semin Neurol. 2007;27:22–31. - PubMed
-
- Lopez OL, Jagust WJ, DeKosky ST, et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study. Part 1. Arch Neurol. 2003;60:1385–1389. - PubMed
-
- Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240–246. - PubMed
Publication types
MeSH terms
Grants and funding
- R01AG177601/AG/NIA NIH HHS/United States
- P50 AG008702/AG/NIA NIH HHS/United States
- R37 MH035636/MH/NIMH NIH HHS/United States
- P01 AG007232/AG/NIA NIH HHS/United States
- P30 AG08051/AG/NIA NIH HHS/United States
- R01 MH035636/MH/NIMH NIH HHS/United States
- P50 AG08702/AG/NIA NIH HHS/United States
- P01 AG007232-200011/AG/NIA NIH HHS/United States
- MH35636/MH/NIMH NIH HHS/United States
- R01AG12101/AG/NIA NIH HHS/United States
- P30 AG008051/AG/NIA NIH HHS/United States
- R01 AG017761/AG/NIA NIH HHS/United States
- R01 AG012101/AG/NIA NIH HHS/United States
- MH55735/MH/NIMH NIH HHS/United States
- MH55646/MH/NIMH NIH HHS/United States
- R01 AG017761-12/AG/NIA NIH HHS/United States
- R01 MH055735/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
